RxDoctor Payments Data

Justin Dunn, MD

Interventional Cardiology · Akron, OHNPI 1902002843

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 53.7% of the total. 2025 is the largest year on record at $52,310, 3.1 times the $16,731 reported in 2019. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$133,025in general payments, 2019–2025

Across 358 payments — averaging $371.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$71K
  • Edwards Lifesciences$23K
  • Shockwave Medical, Inc$14K
  • Philips North America LLC$9K
  • Boston Scientific$7K
  • Medtronic$4K
  • plus $4K from 18 others
$8,349in research payments, 2019–2025

Across 4 payments — averaging $2087.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Philips North America LLC$8K

What the payments were for

  • Consulting fees$35,68527%
  • Speaking & faculty fees$63,55048%
  • Travel & lodging$21,94316%
  • Food & beverage$11,6839%
  • Education$1650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$133,025 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio

Medicare billing

Part B allowed, 2024
$80,111
Medicare patients
321
Services billed
759

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$37,705
BrilintaTicagrelor26$26,034
XareltoRivaroxaban23$20,625
VascepaIcosapent Ethyl18$7,821
Ranolazine ErRanolazine13$1,522
Ezetimibe97$1,261
ClopidogrelClopidogrel Bisulfate147$874
Metoprolol Succinate93$872
Atorvastatin Calcium98$808
Carvedilol78$714
Rosuvastatin Calcium119$605
Losartan Potassium84$580
Metoprolol Tartrate48$388
Spironolactone36$300
Pantoprazole Sodium48$268

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →